Quantification of perifosine, an alkylphosphocholine anti-tumour agent, in plasma by pneumatically assisted electrospray tandem mass spectrometry coupled with high-performance liquid chromatography |
| |
Authors: | N G Knebel S Grieb M Winkler M Locher E van der Vlis E R Verheij |
| |
Institution: | a Department of Biological Research Biochemistry, ASTA Medica AG, Weismuellerstrasse 45, 60314 Frankfurt, Germany;b TNO Nutrition and Food Research Institute, Utrechtseweg 48, P.O. Box 360, 3700 AJ Zeist, The Netherlands |
| |
Abstract: | An HPLC assay with tandem mass spectrometric detection in the positive-ion Turbo-Ion-Spray™ (TISP) mode for the fast and sensitive determination of perifosine ((I), D-21266) in human plasma was developed, utilising the structural analogue, miltefosine ((II), D-18506), as internal standard. Automated solid-phase extraction of diluted plasma samples, based on 250-μl plasma aliquots, at pH 6.5, allowed a reliable quantification of perifosine down to 4 ng/ml. Injection of 200 μl of plasma extracts onto a 100×3 mm normal-phase analytical column at a flow-rate of 0.5 ml/min provided retention-times of 2.4 and 2.1 min for perifosine (I) and the internal standard (II), respectively. The standard curves were linear from 4 to 2000 ng/ml using weighted linear regression analysis (1/Y2). The inter-assay and intra-assay accuracies for the calibration standards were within +0.9% and −0.2%, exhibiting precisions (C.V.) of ±6.5 and ±7.3%, respectively. Up to 100 unknowns may be analysed each 24 h per analyst. |
| |
Keywords: | Perifosine Alkylphosphocholine |
本文献已被 ScienceDirect 等数据库收录! |
|